2022
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicenter study Tamburrino D, de Pretis N, Pérez-Cuadrado-Robles E, Uribarri-Gonzales L, Ateeb Z, Belfori G, Maisonneuve P, Capurso G, Vanella G, Petrone MC, Arcidiacono PG, Vaalavuo Y, Frulloni L, Dominguez-Munoz JE, Deprez PH, Falconi M, del Chiaro M, Crippa S, Laukkarinen J. Br J Surg 2022 May 3; znac103. Online ahead of print. doi: 10.1093/bjs/znac103, PMID:35511697 (Course 8)
2020
Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Replacement Therapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis Iglesia D, Avci B, Kiriukova M, Panic N, Bozhychko M, Sandru V, de-Madaria E, Capurso G.United European Gastroenterol J. 2020 ;8(9):1115-1125. doi: 10.1177/2050640620938987. PMID: 32631175
Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead to a similar oncological outcome compared to non-aged patients - Results of the RESPECT-Study Weniger M, Moir J, Damm M, Maggino L, Kordes M, Rosendahl J, Ceyhan G, Schorn S, RESPECT study group Surg Oncol 2020 Dec;35:285-297. doi: 10.1016/j.suronc.2020.08.031.Epub 2020 Sep 7
Respect – A Multicenter Retrospective Study on Preoperative Chemotherapy in Locally Advanced and Borderline Resectable Pancreatic Cancer Weniger M, Moir J, Damm M, Maggino L, Kordes M, Rosendahl J, Ceyhan GO, Schorn S; RESPECT-study group. Pancreatology. 2020;20(6):1131-8. doi: 10.1016/j.pan.2020.06.012. PMID: 32739267
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer Khomiak A, Brunner M, Kordes M, Lindblad S, Miksch R, Öhlund D, Regel Cancers (Basel). 2020 Nov 2;12(11):3234. DOI: 10.3390/cancers12113234
The quality of pain management in pancreatic cancer: A prospective multi-center study Damm M, Weniger M, Kölsch AK, Lampert C, Ceyhan G, Beer S, Schorn S, Moir J, Michl P, Rosendahl J Pancreatology 2020 Oct;20(7):1511-1518. doi: 10.1016/j.pan.2020.08.017.Epub 2020 Aug 28
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer Kiriukova M, De La Iglesia Garcia D, Panic N, Bozhychko M, Avci B, Maisonneuve P, de-Madaria E, Capurso G, Sandru V. Front Med (Lausanne) 2020 Sep 3;7:495. doi: 10.3389/fmed.2020.00495. PMID: 33015088
Study Protocol of the ESAP Study: Endoscopic Papillectomy vs Surgical Ampullectomy vs. Pancreaticduodenectomy for Ampullary Neoplasm – A Pancreas 2000/EPC Study Hollenbach M, Ali EA, Auriemma F, Gulla A, Heise C, Regnér S, Gaujoux S.Front Med (Lausanne). 2020 May 6;7:152. doi: 10.3389/fmed.2020.00152. PMID: 32435644
In the Era of the Leeds Protocol: A Systematic Review and a Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients Kurlinkus B, Ahola R, Zwart E, Halimi A, Yilmaz BS, Ceyhan GO, Laukkarinen J. Scand J. Surg. 2020 Mar;109(1):11-17.
2019
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe Javed MA, Beyer G, Le N, Vinci A, Wong H, Palmer D, Morgan RD, Lamarca A, Hubner RA, Valle JW, Alam A, Chowdhury S, TingMa Y, Archibugi A, Capurso G, Maisonneuve P, Neesse A, Sund M, Schober M, Krug S. Pancreatology 2019;19(1):97-104. doi: 10.1016/j.pan.2018.10.003. PMID: 30529068
2018
Risk of Malignancy in Resected Pancreatic Mucinous Cystic Neoplasms Keane MG, Shamali A, Nilsson LN, Antila A, Millastre Bocos J, Marijinissen Van Zanten M, Verdejo Gil C, Maisonneuve P, Vaalavuo Y, Hoskins T, Robinson S, Ceyhan GO, Abu Hilal M, Pereira SP, Laukkarinen J, Del Chiaro M Br J Surg. 2018 Mar;105(4):439-446. doi: 10.1002/bjs.10787.
2016
Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results From A Pan-European Questionnaire Study Le N, Vinci A, Schober M, Krug S, Javed MA, Kohlmann T, Sund M, Neesse A, Beyer G Digestion. 2016;94(4):222-229. doi: 10.1159/000453257. Epub 2016 Dec 29.
Prognostic and Predictive Markers in Pancreatic Adenocarcinoma Le N, Sund M, Vinci A; GEMS Collaborating Group of Pancreas 2000 Dig Liver Dis. 2016 Mar;48(3):223-30. doi: 10.1016/j.dld.2015.11.001. Epub 2015 Nov 14.
Nature and Management of Pancreatic Mucinous Cystic Neoplasm (MCN): A Systematic Review of the Literature Nilsson LN, Keane MG, Shamali A, Millastre Bocos J, Marijinissen van Zanten M, Antila A, Verdejo Gil C, DelChiaro M, Laukkarinen J. Pancreatology. 2016 Nov - Dec;16(6):1028-1036. doi: 10.1016/j.pan.2016.09.011. Epub 2016 Sep 20.
2015
New Advances in the Treatment of Metastatic Pancreatic Cancer
Schober M, Javed MA, Beyer G, Le N, Vinci A, Sund M, Neesse A, Krug S
Digestion. 2015;92(3): 175-84
Increased Incidence of Extrapancreatic Neoplasms in Patients with IPMN: Fact or Fiction? A Critical Systematic Review
Pugliese L, Keskin M, Maisonneuve P, D'Haese JG, Marchegiani G, Wenzel P, Del Chiaro M, Ceyhan GO.
Pancreatology. 2015 May-Jun; 15(3):209-16/j.pan.2015.03.007. Epub 2015 Mar 18.
Association Between Pancreatic Intraductal Papillary Mucinous Neoplasms and Extrapancreatic Malignancies
Marchegiani G, Malleo G, D'Haese JG, Wenzel P, Keskin M, Pugliese L, Borin A, Benning V, Nilsson L, Oruc N, Segersvard R, Friess H, Schmid R, Löhr M, Maisonneuve P, Bassi C, Ceyhan GO, Salvia R, Del Chiaro M.
Clin Gastroenterol Hepatol 2015 Jun; 13(6): 1162-9. doi. 10.1016/j.cgh.2014.11.029. Epub 2014 Dec 2.
Influence of Cachexia and Sarcopenia on Survival in Pancreatic Ductal Adenocarcinoma: A Systematic Review Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, Charnley RM, Lyadov V Pancreatology. 2015 Jan-Feb;15(1):19-24. doi: 10.1016/j.pan.2014.11.006. Epub 2014 Dec 4.
2007
Pancreaticduodenectomy for Peri-Ampullary Neoplasia Leads to Specific Micronutrient Deficiencies Armstrong T, Strommer L, Ruiz-Jasbon F, Shek FW, Harris SF, Permert J, Johnson CD Pancreatology. 2007;7(1):37-44. Epub 2007 Apr 18.
2005
Does Anyone Survive Pancreatic Ductal Adenocarcinoma? A Nationwide Study Re-Evaluating the Data of the Finnish Cancer Registry Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, Haglund C. Gut. 2005 Mar;54(3):385-7.